{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:14:46Z","timestamp":1792692886893,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:p>Mucormycosis, a rare fungal disease has emerged as a new epidemic in India, during the CoronaVirus Disease 2019 (COVID-19) pandemic. Mucormycosis is caused by the mucormycetes group of molds. Immunocompromised states such as diabetes, chronic steroid use, and patients receiving immunosuppressant drugs are the risk factors for mucormycosis. The second wave of the COVID-19 pandemic has also invited the notorious mucormycosis in the current scenario. India has announced mucormycosis as a notifiable disease in May 2021, as the number of COVID-19-associated mucormycosis cases has increased swiftly. There are different opinions and evidence for the emergence of mucormycosis or the so-called \u2018black fungus\u2019. It is proposed that the use of steroids, monoclonal antibodies, and prolonged hospitalization in the treatment of COVID-19 has substantially decreased the immunity in COVID-19-affected patients and maybe the reason for the emergence of fungal infections. The other hypothesis is that improper disinfection procedures such as using non-sterile water for humidification of oxygen can be the reason. Or, the COVID-19 infection itself produces an immunocompromised and diabetic-like state is again a question. This review mainly focuses on the discussion and identification of the most common risk factor for mucormycosis, investigations, and management of mucormycosis.<\/jats:p>","DOI":"10.4103\/jfmpc.jfmpc_1186_21","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T11:54:47Z","timestamp":1645876487000},"page":"418-423","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["COVID19 associated mucormycosis: A review"],"prefix":"10.4103","volume":"11","author":[{"given":"Priyadharsini R.","family":"Palanisamy","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Karaikal, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhivya","family":"Elango","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Karaikal, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"B2-20240828","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.idc.2021.03.009","article-title":"Mucormycosis","volume":"35","author":"Steinbrink","year":"2021","journal-title":"Infect Dis Clin North Am"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/microorganisms9030523","article-title":"Epidemiology of mucormycosis in India","volume":"9","author":"Prakash","year":"2021","journal-title":"Microorganisms"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China:A descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China:A single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B7-20240828","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.15190\/d.2021.5","article-title":"High mortality co-infections of COVID19-19 patients:Mucormycosis and other fungal infections","volume":"9","author":"Bhatt","year":"2021","journal-title":"Discoveries"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-020-00243-2","article-title":"COVID-19:Immunopathogenesis and immunotherapeutics","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B9-20240828","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/jof7040298","article-title":"When uncontrolled diabetes mellitus and severe COVID19-19 converge:The perfect storm for mucormycosis","volume":"7","author":"John","year":"2021","journal-title":"J Fungi"},{"key":"B10-20240828","doi-asserted-by":"crossref","first-page":"110613","DOI":"10.1016\/j.mehy.2021.110613","article-title":"Does COVID19 19 generate a milieu for propagation of mucormycosis?","volume":"152","author":"Pandiar","year":"2021","journal-title":"Med Hypotheses"},{"key":"B11-20240828","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID19-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"B12-20240828","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID19-19:A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","article-title":"Coronavirus disease (COVID19-19) associated mucormycosis (CAM):Case report and systematic review of literature","volume":"186","author":"Garg","year":"2021","journal-title":"Mycopathologia"},{"key":"B14-20240828","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ajem.2020.09.032","article-title":"Mucormycosis with orbital compartment syndrome in a patient with COVID-19","volume":"42","author":"Werthman-Ehrenreich","year":"2021","journal-title":"Am J Emerg Med"},{"key":"B15-20240828","first-page":"e10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"746","DOI":"10.5946\/ce.2020.180","article-title":"Rare and fatal gastrointestinal mucormycosis (zygomycosis) in a COVID-19 patient:A case report","volume":"53","author":"Monte","year":"2020","journal-title":"Clin Endosc"},{"key":"B17-20240828","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/IOP.0000000000001889","article-title":"Acute invasive rhino-orbital mucormycosis in a patient with COVID19-associated acute respiratory distress syndrome","volume":"37","author":"Mekonnen","year":"2021","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"B18-20240828","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/ijo.IJO_3774_20","article-title":"Mucor in a viral land:A tale of two pathogens","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B19-20240828","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/myc.13256","article-title":"The double edged sword of systemic corticosteroid therapy in viral pneumonia:A case report and comparative review of influenza associated mucormycosis versus COVID19 associated mucormycosis","volume":"64","author":"Ahmadikia","year":"2021","journal-title":"Mycoses"},{"key":"B20-20240828","doi-asserted-by":"crossref","first-page":"e241663","DOI":"10.1136\/bcr-2021-241663","article-title":"COVID19-19 triggering mucormycosis in a susceptible patient:A new phenomenon in the developing world?","volume":"14","author":"Revannavar","year":"2021","journal-title":"BMJ Case Rep CP"},{"key":"B21-20240828","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajic.2004.09.007","article-title":"Evaluation of the contaminant organisms of humidifier reservoir water and investigation of the source of contamination in a university hospital in Turkey","volume":"33","author":"Nakipoglu","year":"2005","journal-title":"Am J Infect Control"},{"key":"B24-20240828","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis:An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B25-20240828","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2147\/DDDT.S145545","article-title":"Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis:Design, development, and place in therapy","volume":"12","author":"Jenks","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"B26-20240828","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/TP.0b013e3182577485","article-title":"Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation","volume":"94","author":"Chaftari","year":"2012","journal-title":"Transplantation"},{"key":"B27-20240828","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2217\/fmb-2016-0231","article-title":"The cost of treating mucormycosis with isavuconazole compared with standard therapy in the UK","volume":"12","author":"Bagshaw","year":"2017","journal-title":"Future Microbiol"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1186_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:11:47Z","timestamp":1787166707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1186_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1186_21","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"2021-06-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}